Qtrex Quantum Ltd. · NASDAQ:QTEX
Qtrex Quantum — Inspira Technologies Oxy B.H.N. — Investor Presentation (February 2023)
22 slides from Qtrex Quantum's investor presentation, February 2023
Slide 1: Investor Presentation
Investor Presentation NASDAQ: $IINN, $IINNW •\ February 2023 Copyright © 2018-2023 Inspira Technologies OXY B.H.N. LTD., All rights reserved 1
Slide 2: Forward looking-Statements
Forward looking-Statements This presentation of InspiraTM Technologies Oxy B.H.N. Ltd. (“Inspira Technologies” or the “Company”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act and other securities law. Words such as “expects,” “intends,” “pla
Slide 3: Acute Respiratory Failure: Is Invasive Mechanical Ventilation your only choice?
Acute Respiratory Failure Invasive Mechanical Ventilation (IMV) …is this your ONLY CHOICE? *The INSPIRA ART and the ART presented in this presentation are both referring to the INSPIRA ART. To-date the INSPIRA™ ART System has not been tested Copyright or used on humans and have not been cleared or a
Slide 4: Your right to choose
Creating a New Class of Respiratory Care INSPIRA™ ART System Your right to choose between intubation and coma (IMV) or being awake & breathing spontaneously with the INSPIRA™ ART *The INSPIRA ART and the ART presented in this presentation are both referring to the INSPIRA ART. IMV = Invasive Mechani
Slide 5: Creating Early Revenue Opportunities
Creating Early Revenue Opportunities HYLA™ Blood Sensor ALICE™ Device A non-invasive optical blood sensor being developed using machine An extracorporeal blood circulation device designed to provide cardiac learning based algorithms to measure blood parameters during and pulmonary support extracorpo
Slide 6: Leading the Industry
Leading the Industry INSPIRA™ ART System ALICE™ Device HYLA™ Blood Sensor Respiratory Support Life Support Non-Invasive Blood Parameter Measuring Potential medical device companies to target * Trademarks are the property of their respective owners. To-date the INSPIRA™ ART System, HYLA™ and ALICE™ a
Slide 7: Inspira Achievements
Inspira Achievements https://inspira-technologies.com/news/ Based on Press Releases published by the company from 22nd November 2022 to 23rd January 2023. Copyright © 2018-2023 Inspira Technologies OXY B.H.N. LTD., All rights reserved 7
Slide 8: A Growing Market
A Growing Market Acute Respiratory Failure Trends Global Market Expected to Grow Growing geriatric population (Based on invasive mechanical ventilation market) Increase in the prevalence of Respiratory comorbidities respiratory diseases following COVID-19 1. “Respiratory Care Devices Market by Produ
Slide 9: The Respiratory Gap
The Respiratory Gap Mechanical Ventilation in this presentation is referring to Invasive Mechanical Ventilation. Copyright Copyright © 2018-2023 © 2018-2023 Inspira Inspira 2018-2022 Technologies Technologies OXY B.H.N.B.H.N. LTD., LTD.,LTD., OXY B.H.N. All rights All rights All rights reserved 99 r
Slide 10: Invasive Mechanical Ventilation Puts Patients at Risk
Invasive Mechanical Ventilation Puts Patients at Risk ¹ˉ³ Invasive Intubation & Induced Coma Potential Risks & Complications High Cost of Treatment • Ventilator-induced lung injury (VILI) • Prolonged Ventilation & ICU stay • Ventilator-associated pneumonia (VAP) • Requires weaning process • Ventilat
Slide 11: Play Video
Play Video The INSPIRA ART and the ART presented in this presentation are both referring to the INSPIRA ART. To-date the INSPIRA™ ART System, ALICE™ Device and HYLA™ Blood Sensor have not been tested or used on humans and have not been cleared or approved by the U.S. Food and Drug Administration (FD
Slide 12: INSPIRA™ ART System - Overview
INSPIRA™ ART System - Overview A new class of acute respiratory care Targeted Benefits Breakthrough Augmented Respiration o Designed to assist the compromised lung, by Technology, designed to reduce the need oxygenating a reduced volume of blood to boost for Invasive Mechanical Ventilation (IMV) pat
Slide 13: HYLA™ Blood Sensor - Overview
HYLA™ Blood Sensor- Overview Non-invasive blood measurement Key features (Incl. next generation) A non-invasive optical blood sensor being developed o Continuous & real-time measurements using machine learning based algorithms to measure blood parameters, intended to provide o Measurements: SO2, Hb,
Slide 14: ALICE™ Device - Overview
ALICE™ Device - Overview An extracorporeal blood circulation Key Features device designed to provide cardiac o Intuitive user-centric software and display and pulmonary support o Ergonomic device configuration o Enabling in-hospital patient transfer with integrated Expected Regulatory Pathway - FDA
Slide 15: Go-To-Market Strategy
Go-To-Market Strategy ` Business Model Industry Endorsements Planned Clinical Studies o Razor-Blade business model o Strategic OEM agreements o HYLA, Q1-2023 (Data Collection Analysis) (System + Disposable Kits) o Collaboration, Sheba Medical Center (Ranked in Top-10) o INSPIRA ART, H2-2024 (First i
Slide 16: Planned Product Milestone Timeline
Planned Product Milestone Timeline H1-2023 H2-2023 H1-2024 H2-2024 2025 Clinical Study Start Clinical Study Results V&V FDA Clearance 1st Market Penetration (Data Collection Analysis) (Data Collection Analysis) Verification & Validation Sheba Medical Center Testing Up to 100 patients FDA Submission
Slide 17: Inspira Patent Portfolio
Inspira Patent Portfolio Oxygenator 3 Patent Families Initiation System Pump Family #1. INS-001 A Cannula Fixation Device – Granted in IL November 2022, Filed in U.S. September 2022 Family #2 INS-002 Dual Lumen Cannula and Methods of Use – Granted January 2023 in U.S. Family #3 INS-003 Extracorporea
Slide 18: Inspira Cash Management
Inspira Cash Management Company incorporation $12 million $16 million $9.4 million ~$37.4 million Raised prior to IPO: Raised at initial public Warrants exercised at $5.50 Total cash Including funds from offering on NASDAQ per share Israeli Innovation raised to-date Authority Feb.2018 2019 up to Q1-
Slide 19: Experienced Leadership Team
Experienced Leadership Team Prof. Benad Goldwasser, MD, MBA Dagi Ben-Noon, BSc Joe Hayon, MBA Chairman Co-Founder, Director & CEO Co-Founder, Director & President Multiple well-known industry exits Co-founder of Nano Dimension M&A experience & track record Nasdaq: NNMD • Elscint Technologies • Arazi
Slide 20: Scientific Advisory Board - Several World-Renowned KOLs
Scientific Advisory Board - Several World-Renowned KOLs Prof. Daniel Brodie Prof. Eddy Fan Dr. Stephan Ledot Dr. Yigal Kasif, MD Intensivist & ECMO Advisor Intensivist & ECMO Advisor Intensivist & ECMO Advisor ECMO Advisor President-elect of the Extracorporeal Life Medical director of the extracorpo
Slide 21: Scientific Advisory Board - Several World-Renowned KOLs
Scientific Advisory Board - Several World-Renowned KOLs KOLs = Key Opinion Leaders. Copyright Copyright © 2018-2023 © 2018-2023 Inspira Inspira Technologies Technologies OXY B.H.N. OXY B.H.N. LTD., LTD., All rights All rights reserved 21 reserved 21
Slide 22: US Public Relations
U S P u b l i c Re l a t i o n s D av e G e n t r y •\ Re d C h i p C o m p a n i e s I n c . 1-800-RED-CHIP (733-2447) or 407-491-4498 i n fo @ i n s p i ra o 2 . c o m I I N N @ re d c h i p . c o m w w w. i n s p i ra - t e c h n o l o g i e s . c o m Copyright © 2018-2023 Inspira Technologies OX
Inspira Technologies Oxy B.H.N. — Investor Presentation (February 2023) on 6ix